Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

0.00%

1.4¢ chimeric therapeutics limited

the market doesn't agree with you. Small trial, only 6 out of 11...

First 617 Last

Share
Profile

Follow
Milcom

880 Posts.

217

20/02/24

12:36

Post #: 72498266
Share

Originally posted by dalts66: ↑

I dont agree.

CHM have efficacy against a solid tumour cancer using CarT. That's huge.

They have shown safety and disease control against GBM. Also huge. To have a treatment work across the blood brain barrier and be safe an effective is an incredible accomplishment.

One of the approved FDA drugs for GBM received approval with only 20% response rate. And its mean survival rate is significantly less than what CHM achieved. So even a reduction in response rate over a larger cohort size, as long as safety remains the same, will still see a fast track approval pathway.

So small cohort number or not, the results are indeed impressive.

Lets see what the expansion trial can achieve.

And then of course there is the rest of the pipeline which is also already hitting arms or about to hit arms.

Last time I checked CHM wasn't a charity. So I dont understand why you should expect someone to take a pay cut to come and work for them. Without the right people these drugs wont progress. And the pipeline progressing efficiently and effectively is what determines if a drug discovery biotech succeeds or not.

Expand

the market doesn't agree with you. Small trial, only 6 out of 11 showed disease control. Only 2 out of the 11 showed any promise. That's not good. Hence 2.5c

She took a paycut? Where exactly do you think she was before becoming CEO/MD of CHM?

CHM Price at posting: 2.5¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

There are more pages in this discussion • 271 more messages in this thread...

First 617 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
1.5¢	1.5¢	1.4¢	$15.87K	1.103M

Buyers (Bids)

No.	Vol.	Price($)
2	1876837	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	96056	2

View Market Depth

No.	Vol.	Price($)
2	1876837	0.014
12	2424769	0.013
5	1066816	0.012
4	697817	0.011
4	485142	0.010

Price($)	Vol.	No.
0.015	76056	1
0.016	735854	3
0.017	647827	3
0.018	1788235	5
0.019	987804	3

Last trade - 16.10pm 27/09/2024 (20 minute delay)

CHM (ASX) Chart

the market doesn't agree with you. Small trial, only 6 out of 11...

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

the market doesn't agree with you. Small trial, only 6 out of 11...

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACCC seeks Olam divestments before it can buy Namoi Cotton

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News